GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Total Payout Ratio

Central Pharmaceutical JSC No2 (HSTC:DP2) Total Payout Ratio : 0.00 (As of Jun. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Central Pharmaceutical JSC No2's current Total Payout Ratio is 0.00.


Central Pharmaceutical JSC No2 Total Payout Ratio Historical Data

The historical data trend for Central Pharmaceutical JSC No2's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 Total Payout Ratio Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Total Payout Ratio

Central Pharmaceutical JSC No2 Semi-Annual Data
Total Payout Ratio

Competitive Comparison of Central Pharmaceutical JSC No2's Total Payout Ratio

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical JSC No2's Total Payout Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Total Payout Ratio falls into.



Central Pharmaceutical JSC No2 Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Central Pharmaceutical JSC No2's Total Payout Ratio for the fiscal year that ended in . 20 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- ( + + ) /
=N/A

Central Pharmaceutical JSC No2's Total Payout Ratio for the quarter that ended in . 20 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- ( + + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceutical JSC No2 Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No2's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines